Financhill
Back

Illumina 10K Form

Sell
49

ILMN
Illumina

Last Price:
148.55
Seasonality Move:
9.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive ILMN News And Ratings

See the #1 stock for the next 7 days that we like better than ILMN

ILMN Financial Statistics

Sales & Book Value

Annual Sales: $4.5B
Cash Flow: $383M
Price / Cash Flow: 38.14
Annual Sales: $13.34
Price / Book: 11.62

Profitability

EPS (TTM): -9.96000
Net Income (TTM): $-1.58B
Gross Margin: $2.74B
Return on Equity: -37.83%
Return on Assets: -18.69%

Illumina Earnings Forecast

Key Illumina Financial Ratios

  • The Gross Profit Margin over the past 25 years for ILMN is 60.92%.
  • The Selling, General & Administrative Expenses for ILMN have been equal to 35.79% of Gross Profit Margin.
  • The Research & Development expenses have been 30.06% of Revenue.
  • The Interest Expense is -6.63% of Operating Income.
  • The Net Earning history of ILMN is -25.78% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 16 years.

Illumina Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: ILMN
CUSIP: 452327
Website: illumina.com

Debt

Debt-to-Equity Ratio: 0.94
Current Ratio: 2.43
Quick Ratio: 1.68

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 35.11

ILMN Technical Analysis vs Fundamental Analysis

Sell
49
Illumina (ILMN) is a Sell

Is Illumina a Buy or a Sell?

  • Illumina stock is rated a Sell
    The current Illumina [ILMN] share price is $154.96. The Score for ILMN is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.